James E. Wagner Cultivation logo

James E. Wagner Cultivation(OTC) JWCAF

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2018)-100%
5 Year-100%
1 Year+0%
1 Month+0%
$0.00
+0.00%
+0.00Today
James E. Wagner Cultivation last closing stock price
MetricPriceDate
Last closeUSD 0.002026-10-06
James E. Wagner Cultivation stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-08-05
1 month+0%USD 0.002026-08-05
3 month+0%USD 0.002026-04-02
Year to date+0%USD 0.002025-09-30
1 year+0%USD 0.002025-09-30
3 year+0%USD 0.002023-09-25
5 year-99.67%USD 0.002021-10-04
Since inception-100%USD 0.702018-06-25

James E. Wagner Cultivation Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$2.51M

Net Income (TTM)

-CA$8.09M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-3.39 (Low)

Price

$0.00

Volume

3,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Feb 20, 2026

JWCAF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About James E. Wagner Cultivation

James E. Wagner Cultivation Corporation is a Canadian company focused on the growth and supply of cannabis for medical purposes. The firm utilizes its proprietary aeroponic cultivation technology, known as GrowthSTORM, to produce high-quality cannabis products.

Products and Services
  • Medical cannabis products tailored for patient needs
  • Innovative aeroponic cultivation technology for efficient production
  • Commitment to purity and uniformity in cannabis offerings
Growth Outlook
  • Established in 2007, the company has a strong operational foundation
  • Focus on expanding market share in the growing cannabis industry
  • Investment in technology aims to enhance production efficiency
Financial Highlights
  • Recent quarterly revenue of CAD 236,600, showing potential for growth
  • Trailing twelve months (TTM) net income margin of -3.28%, indicating ongoing challenges
  • Current ratio of 1.48 suggests adequate short-term financial health
James E. Wagner Cultivation Corporation operates in the specialized drug manufacturing sector, primarily focusing on medical cannabis. The company’s unique GrowthSTORM technology sets it apart in a competitive market, allowing for the cultivation of high-quality cannabis. Despite facing financial challenges, including a negative net income margin, the company is positioned to leverage its innovative practices and established market presence for future growth. The current ratio indicates that the company maintains a healthy balance between its current assets and liabilities, which is crucial for navigating the evolving cannabis landscape.
AI Generated • Sep 27, 2026

Industry

Pharmaceuticals

Headquarters

Kitchener, ON N2R 1J4, CA

JWCAF Financials

Key Financial Metrics (TTM)

Gross Margin

-89.21%

Operating Margin

-433.14%

Net Income Margin

-327.95%

Return on Equity

-45.01%

Return on Capital

-55.43%

Return on Assets

-31.94%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

0

Volume

3.00K

Avg. Volume

100

Financials (TTM)

Gross Profit

CA$2.91M

Operating Income

-CA$7.22M

EBITDA

-CA$4.93M

Operating Cash Flow

-CA$13.29M

Capital Expenditure

-CA$8.42M

Free Cash Flow

-CA$21.71M

Cash & ST Invst.

CA$321.04K

Total Debt

CA$20.67M

James E. Wagner Cultivation Performance Analysis

James E. Wagner Cultivation sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22019-03-31-2.4%
Q32019-06-3039.6%
Q42019-09-3031.5%
Q12019-12-31-76.0%
James E. Wagner Cultivation sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22019-03-31-33.3%
Q32019-06-3088.0%
Q42019-09-30100.0%
Q12019-12-31N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q1 2020YOY CHG

Revenue

CA$236.60K

-57.0%

Gross Profit

CA$1.80M

+16478.8%

Gross Margin

7.62%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

160

N/A

Net Income

-CA$1.17M

+49.8%

EBITDA

CA$135.38K

+106.1%

Quarterly Fundamentals

Name
Q1 2020YOY CHG

Total Cash

CA$321.04K

-96.4%

Total Debt

CA$20.67M

+258386.6%

Accounts Receivable

CA$319.38K

-77.6%

Inventory

CA$6.78M

+399.9%

Long Term Debt

CA$17.10M

+366532.6%

Short Term Debt

CA$3.58M

+107176.7%

Return on Assets

-31.94%

N/A

Return on Invested Capital

-54.84%

N/A

Free Cash Flow

-CA$3.53M

+38.1%

Operating Cash Flow

-CA$3.03M

-484.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AQSZFAequus Pharmaceuticals Inc.
$0.00+0.00%
CNGGFCann Group Limited
$0.00+0.00%
ISOLFIsodiol International Inc.
$0.00+0.00%
KHTRFKnight Therapeutics Inc.
$7.71+2.94%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$89.85-5.79%
NVDANvidia
$214.13-1.43%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$93.67-12.74%
CCCCCC Intelligent Solutions
$7.61-0.26%

Questions About JWCAF

What is the current price of James E. Wagner Cultivation?

James E. Wagner Cultivation is trading at $0.00 per share.

What is the 52-week range for James E. Wagner Cultivation?

Over the past 52 weeks, James E. Wagner Cultivation has traded between $0.00 and $0.00.

How much debt does James E. Wagner Cultivation have?

James E. Wagner Cultivation total debt is unavailable.

How much cash does James E. Wagner Cultivation have on hand?

James E. Wagner Cultivation does not have cash on hand data available.

What is James E. Wagner Cultivation’s dividend yield?

James E. Wagner Cultivation does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.